Protein Chip Witnesses Greater Adoption in Clinical Research, and Drug Discovery

Protein chip, technically a protein microarray method, has been a promising high-throughput approach used in disease rate monitoring, and clinical diagnostics. While it has become a vital tool for use in large-scale biology experiments over the past couple of decades, considerably high demand is expected to come in from clinical research, diagnostics, and drug discovery segments. Rampantly growing prevalence of cancers is expected to remain an important driver behind surging adoption of protein chip by researchers. The top barrier to rising life expectancy worldwide, cancer remains the leading mortality cause behind roughly 10 million deaths across the globe in 2020.

Moreover, there was an estimated 19+ million new cancer cases the same year, according to the World Health Organization (WHO) statistics. The recent past has witnessed development of the various efficient, reliable, and advanced diagnostic technologies, which is also a strong factor driving protein chip demand. As protein chips enable faster, easier, and parallel tracking of a large number of addressable protein-protein interactions, small molecule targets, protein–phospholipid interactions, and substrates of proteins kinases, protein microarray will remain a preferred tool in the world of molecular biology, and biochemistry. With personalised medicine firming up, protein chip technique will also most likely take off.

Proteomics Key Revenue Generator; Diagnostics Promises Substantial Protein Chip Adoption

Proteomics, a significant revenue generator for the protein chip market by 2019, continues to find application in drug discovery, as well as biomedical research. Continued preference for proteomics for applications like chromatography, superficial fluid chromatography, X-ray crystallography, spectroscopy, protein fractionation, surface plasmon resonance, and electrophoresis also places it ahead of other protein chip applications. Proteomics has been proven to provide a more accurate picture of the desired (in-vivo) outcome, and remains a chosen tool for effective research on disease pathogenesis, study of tumour resistance mechanisms, and therapeutic developments.

While protein functional analysis also remains a sought-after area of application, the massive opportunity emerging in the field of diagnostics points to exponential demand growth in the near future. The global COVID-19 pandemic particularly has been creating multiple windows of opportunities for protein chip market players. With growing interest around protein identification and protein-virus interactions through various tests that aid in understanding a patient’s body vitals, biotech companies are showing greater preference for protein chips. The fact that vaccination at a global will take a lot of time than was expected to, further complements the growing protein chip consumption amid pandemic.

When it comes to analysing protein chip adoption based on the underlying technology, functional protein microarray will continue to gain heavy traction for research studies in protein function areas. Analytical microarrays, and reverse phase protein microarray are also expected to remain prominent technology types – the former exhibiting decent growth in rate of adoption on account of lower costs involved, and higher throughput.

Inadequate Protein Yield of Desired Quality Continues to Challenge Market Growth

Despite exploding application potential within the field of advanced disease diagnostics, there are certain challenges that continue to play out as an obstacle decelerating the growth of the protein chip market in long run. High-quality protein production in a high-throughput fashion has been a longstanding challenge facing biotech companies. Retaining the quality of proteins for longer in order to maintain the final protein microarray quality is another factor that continues to challenge researchers as it critically requires stable microenvironment. Scarce availability of high-quality proteins on the market is thus a major deterrent to market growth. Low protein yield of desired consistency, quality, and reliability is expected to remain a long-term growth limiting factor for the protein chip market throughout the period of forecast.

North America, and Europe Remain Lucrative; Asia Pacific Exhibits High Potential

In 2019, North America maintained the lead in the global market for protein chip, closely trailed by Europe. Strong presence of top biotech companies, coupled with considerably significant funding allotted to collaborative research activities, will continue to uphold dominance of the region in global landscape. The European market, on the other hand, is expected to benefit from the rising cancer prevalence, and the subsequently growing interest around leveraging protein chip as a prime research tool. Top-notch healthcare quality, expansion of all related aspects of healthcare, and government support to molecular biology, and biotechnological research collectively account for the position of Europe as one of the top protein chip markets. Led by China, and India, the market in Asia Pacific is also projected to exhibit remarkable performance in terms of protein chip adoption, especially in the diagnostics segment. COVID-19 diagnostics has further provided an impetus to the use of protein chips in critical diagnosis.

Key Companies in Global Protein Chip Market

Some of the key companies operating in the global protein chip market include Sigma Aldrich Corporation, SEQUENOM, Inc., Biacore, EMD Millipore, Illumina, Inc., Agilent Technologies, Affymetrix, Inc., HTS Biosystems, Life Technologies Corporation, Ciphergen Biosystems, and Lumicyte.

Regional Classification of the Global Protein Chip Market is Listed Below:

North America

U.S.
Canada

Europe

Germany
France
Spain
U.K.
Italy
Russia
Rest of Europe

Asia Pacific

China
Japan
India
Southeast Asia
Rest of Asia Pacific

Latin America

Brazil
Mexico
Rest of Latin America

Middle East and Africa

GCC
South Africa
Rest of Middle East & Africa

*Regions and countries are subject to change based on data availability.

Key Elements Included In The Study: Global Protein Chip Market

Protein Chip Market by Product/Technology/Grade, Application/End-user, and Region
Executive Summary (Opportunity Analysis and Key Trends)
Historical Market Size and Estimates, Value, 2018 - 2022
Market Value at Regional and Country Level, 2023 - 2030
Market Dynamics and Economic Overview
Market Size in Value, Growth Rates, and Forecast Figures, 2023 - 2030
Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies
Regional and Product/Grade/Application/End-user Price Trends Analysis
Value Chain and Five Force’s Analysis
Regional/Sub-region/Country Market Size and Trend Analysis
Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

The report will be prepared in a PPT format and will be delivered in a PDF format.

Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.

If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.

If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.

If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.

1. Executive Summary
1.1. Global Protein Chip Market Outlook, 2018 - 2030 (US$ Million)
1.2. Global Protein Chip Market Incremental Opportunity, 2018 - 2030 (US$ Million)
1.3. Key Industry Trends

2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.1.1. Driver 1
2.2.1.2. Driver 2
  2.2.2. Restraints
2.2.2.1. Restraint 1
2.2.2.2. Restraint 2
  2.2.3. Market Opportunities Matrix
2.3. Porters Five Forces Analysis
2.4. Regulatory Guidelines & Reimbursement Scenario
2.5. Covid-19 Impact Analysis

3. Pricing Analysis, 2021
3.1. Average Selling Price, by Key Regions

4. Global Protein Chip Market Outlook, 2018 - 2030
4.1. Global Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
  4.1.1. Key Highlights
4.1.1.1. Functional
4.1.1.2. Analytical
4.1.1.3. Reverse Phase
4.1.1.4. Others
  4.1.2. BPS Analysis/Market Attractiveness Analysis

5. Global Protein Chip Market Outlook, 2018 - 2030
5.1. Global Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
  5.1.1. Key Highlights
5.1.1.1. Diagnostics
5.1.1.2. Proteomics
5.1.1.3. Drug Discovery
5.1.1.4. Biomarker Research
5.1.1.5. Others
  5.1.2. BPS Analysis/Market Attractiveness Analysis
5.2. Global Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  5.2.1. Key Highlights
5.2.1.1. Pharmaceutical & Biotech Companies
5.2.1.2. Hospitals & Clinics
5.2.1.3. Diagnostic Laboratories
5.2.1.4. Research Institutes
5.2.1.5. Others
  5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Global Protein Chip Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
  5.3.1. Key Highlights
5.3.1.1. North America
5.3.1.2. Europe
5.3.1.3. Asia Pacific
5.3.1.4. Rest of the World
  5.3.2. BPS Analysis/Market Attractiveness Analysis

6. North America Protein Chip Market Outlook, 2018 - 2030
6.1. North America Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
  6.1.1. Key Highlights
6.1.1.1. Functional
6.1.1.2. Analytical
6.1.1.3. Reverse Phase
6.1.1.4. Others
  6.1.2. BPS Analysis/Market Attractiveness Analysis
6.2. North America Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
  6.2.1. Key Highlights
6.2.1.1. Diagnostics
6.2.1.2. Proteomics
6.2.1.3. Drug Discovery
6.2.1.4. Biomarker Research
6.2.1.5. Others
  6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. North America Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  6.3.1. Key Highlights
6.3.1.1. Pharmaceutical & Biotech Companies
6.3.1.2. Hospitals & Clinics
6.3.1.3. Diagnostic Laboratories
6.3.1.4. Research Institutes
6.3.1.5. Others
  6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  6.4.1. Key Highlights
6.4.1.1. U.S.
6.4.1.2. Canada
  6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Protein Chip Market Outlook, 2018 - 2030
7.1. Europe Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
  7.1.1. Key Highlights
7.1.1.1. Functional
7.1.1.2. Analytical
7.1.1.3. Reverse Phase
7.1.1.4. Others
  7.1.2. BPS Analysis/Market Attractiveness Analysis
7.2. Europe Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
  7.2.1. Key Highlights
7.2.1.1. Diagnostics
7.2.1.2. Proteomics
7.2.1.3. Drug Discovery
7.2.1.4. Biomarker Research
7.2.1.5. Others
  7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Europe Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  7.3.1. Key Highlights
7.3.1.1. Pharmaceutical & Biotech Companies
7.3.1.2. Hospitals & Clinics
7.3.1.3. Diagnostic Laboratories
7.3.1.4. Research Institutes
7.3.1.5. Others
  7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Europe Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  7.4.1. Key Highlights
7.4.1.1. Germany
7.4.1.2. France
7.4.1.3. U.K.
7.4.1.4. Italy
7.4.1.5. Spain
7.4.1.6. Rest of Europe
  7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Protein Chip Market Outlook, 2018 - 2030
8.1. Asia Pacific Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
  8.1.1. Key Highlights
8.1.1.1. Functional
8.1.1.2. Analytical
8.1.1.3. Reverse Phase
8.1.1.4. Others
  8.1.2. BPS Analysis/Market Attractiveness Analysis
8.2. Asia Pacific Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
  8.2.1. Key Highlights
8.2.1.1. Diagnostics
8.2.1.2. Proteomics
8.2.1.3. Drug Discovery
8.2.1.4. Biomarker Research
8.2.1.5. Others
  8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Asia Pacific Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  8.3.1. Key Highlights
8.3.1.1. Pharmaceutical & Biotech Companies
8.3.1.2. Hospitals & Clinics
8.3.1.3. Diagnostic Laboratories
8.3.1.4. Research Institutes
8.3.1.5. Others
  8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  8.4.1. Key Highlights
8.4.1.1. China
8.4.1.2. Japan
8.4.1.3. India
8.4.1.4. South Korea
8.4.1.5. Australia & New Zealand
8.4.1.6. Rest of Asia Pacific
  8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Rest of the World Protein Chip Market Outlook, 2018 - 2030
9.1. Rest of the World Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
  9.1.1. Key Highlights
9.1.1.1. Functional
9.1.1.2. Analytical
9.1.1.3. Reverse Phase
9.1.1.4. Others
  9.1.2. BPS Analysis/Market Attractiveness Analysis
9.2. Rest of the World Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
  9.2.1. Key Highlights
9.2.1.1. Diagnostics
9.2.1.2. Proteomics
9.2.1.3. Drug Discovery
9.2.1.4. Biomarker Research
9.2.1.5. Others
  9.2.2. BPS Analysis/Market Attractiveness Analysis
9.3. Rest of the World Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  9.3.1. Key Highlights
9.3.1.1. Pharmaceutical & Biotech Companies
9.3.1.2. Hospitals & Clinics
9.3.1.3. Diagnostic Laboratories
9.3.1.4. Research Institutes
9.3.1.5. Others
  9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Rest of the World Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  9.4.1. Key Highlights
9.4.1.1. Latin America
9.4.1.2. Middle East & Africa
  9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape
10.1. Company Market Share Analysis
10.2. Company Profiles
  10.2.1. ArrayIt Corporation
10.2.1.1. Company Overview
10.2.1.2. Financial Overview
10.2.1.3. Technology Portfolio
10.2.1.4. Recent Developments
*Above details will include, but not be limited to below list of companies based on availability
  10.2.2. PerkinElmer, Inc.
  10.2.3. Thermo Fischer Scientific
  10.2.4. Lumicyte
  10.2.5. Bio-Rad Laboratories
  10.2.6. Illumina, Inc.
  10.2.7. Ciphergen Biosystems
  10.2.8. Agilent Technologies
  10.2.9. Others

11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations

Protein Chip Market

Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Request Table of Contents

Latest Reports

Our Research Methodology